GLP1R and cardiovascular disorder: The most frequently used keywords in the most cited papers and keywords identified in cooccurrence analysis in the most recent articles are semaglutide, obesity, diabetes mellitus type 2, glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, antidiabetic agent, liraglutide, and cardiovascular disease.